Answers are grounded in this paper and cite their sources.
Chemoradiotherapy is increasingly used in advanced laryngeal cancers. Failures are generally managed by surgery. They include histologically confirmed recurrent or residual disease or a symptomatic life threatening treatment sequelae. Tumour recurrence or residivism can be managed by chemotherapy when radical surgery is either refused by the patient or if the general condition of the patient do not permit it. However surgery becomes inevitable when life threatening treatment sequelae like absolute pharyngo-oesophageal stricture and aspiration sets in.
No takes yet. Share an insight, caveat, or question.
Varghese et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: